Ausgabe 2/2010
Inhalt (28 Artikel)
A novel doxorubicin-mitomycin C co-encapsulated nanoparticle formulation exhibits anti-cancer synergy in multidrug resistant human breast cancer cells
Adam J. Shuhendler, Richard Y. Cheung, Janet Manias, Allegra Connor, Andrew M. Rauth, Xiao Yu Wu
Small inhibitor of Bcl-2, HA14-1, selectively enhanced the apoptotic effect of cisplatin by modulating Bcl-2 family members in MDA-MB-231 breast cancer cells
Elif Damla Arisan, Ozgur Kutuk, Tugsan Tezil, Cagri Bodur, Dilek Telci, Huveyda Basaga
Transferrin receptor (CD71) is a marker of poor prognosis in breast cancer and can predict response to tamoxifen
Hany Onsy Habashy, Desmond G. Powe, Cindy M. Staka, Emad A. Rakha, Graham Ball, Andrew R. Green, Mohammed Aleskandarany, E. Claire Paish, R. Douglas Macmillan, Robert I. Nicholson, Ian O. Ellis, Julia M. W. Gee
Identification and characterization of two novel germ line p53 mutations in the non-LFS/non-LFL breast cancer families in Chinese population
A-Yong Cao, Wei Jin, Peng-Cheng Shi, Gen-hong Di, Zhen-Zhou Shen, Zhi-Ming Shao
Decreased TGFβ signaling and increased COX2 expression in high risk women with increased mammographic breast density
Wei Tse Yang, Michael T. Lewis, Kenneth Hess, Helen Wong, Anna Tsimelzon, Nese Karadag, Michelina Cairo, Caimaio Wei, Funda Meric-Bernstam, Powel Brown, Banu Arun, Gabriel N. Hortobagyi, Aysegul Sahin, Jenny C. Chang
Relationship between oestrogen receptor status and proliferation in predicting response and long-term outcome to neoadjuvant chemotherapy for breast cancer
Robin L. Jones, Janine Salter, Roger A’Hern, Ash Nerurkar, Marina Parton, Jorge S. Reis-Filho, Ian E. Smith, Mitchell Dowsett
Defining the therapeutic window of vertebral photodynamic therapy in a murine pre-clinical model of breast cancer metastasis using the photosensitizer BPD-MA (Verteporfin)
Margarete K. Akens, Michael R. Hardisty, Brian C. Wilson, Joerg Schwock, Cari M. Whyne, Shane Burch, Albert J. M. Yee
Proliferative genes dominate malignancy-risk gene signature in histologically-normal breast tissue
Dung-Tsa Chen, Aejaz Nasir, Aedin Culhane, Chinnambally Venkataramu, William Fulp, Renee Rubio, Tao Wang, Deepak Agrawal, Susan M. McCarthy, Mike Gruidl, Gregory Bloom, Tove Anderson, Joe White, John Quackenbush, Timothy Yeatman
Association of low tumor RNA integrity with response to chemotherapy in breast cancer patients
Amadeo M. Parissenti, Judy-Anne W. Chapman, Harriette J. Kahn, Baoqing Guo, Lei Han, Patti O’Brien, Mark P. Clemons, Roberta Jong, Rebecca Dent, Barbara Fitzgerald, Kathleen I. Pritchard, Lois E. Shepherd, Maureen E. Trudeau
Ljubljana nomograms for predicting the likelihood of non-sentinel lymph node metastases in breast cancer patients with a positive sentinel lymph node
Andraž Perhavec, Maja Pohar Perme, Marko Hočevar, Nikola Besić, Janez Žgajnar
Adipocyte fatty acid-binding protein as a novel prognostic factor in obese breast cancer patients
K. Hancke, D. Grubeck, N. Hauser, R. Kreienberg, J. M. Weiss
Phosphatidyl-inositol-3-kinase alpha catalytic subunit mutation and response to neoadjuvant endocrine therapy for estrogen receptor positive breast cancer
Matthew J. Ellis, Li Lin, Robert Crowder, Yu Tao, Jeremy Hoog, Jacqueline Snider, Sherri Davies, Katherine DeSchryver, Dean B. Evans, Jutta Steinseifer, Raj Bandaru, WeiHua Liu, Humphrey Gardner, Vladimir Semiglazov, Mark Watson, Kelly Hunt, John Olson, José Baselga
Screening for clonal hematopoiesis as a predictive marker for development of therapy-related myeloid neoplasia (t-MN) following neoadjuvant therapy for breast cancer: a Southwest Oncology Group study (S0012)
Marilyn L. Slovak, Victoria Bedell, Danika Lew, Kathy S. Albain, Georgiana K. Ellis, Robert B. Livingston, Silvana Martino, Edith A. Perez, Gabriel N. Hortobagyi, Dorie Sher, Wendy Stock
Assessment of false-negative cases of breast MR imaging in women with a familial or genetic predisposition
Inge-Marie A. Obdeijn, Claudette E. Loo, Adriana J. Rijnsburger, Martin N. J. M. Wasser, Elisabeth Bergers, Theo Kok, Jan G. M. Klijn, Carla Boetes
Breast cancer risks in individuals testing negative for a known family mutation in BRCA1 or BRCA2
S. M. Domchek, M. M. Gaudet, J. E. Stopfer, M. H. Fleischaut, J. Powers, N. Kauff, K. Offit, K. L. Nathanson, M. Robson
The impact of preoperative breast MRI on the re-excision rate in invasive lobular carcinoma of the breast
R. M. Mann, C. E. Loo, T. Wobbes, P. Bult, J. O. Barentsz, K. G. A. Gilhuijs, C. Boetes
Variation in genes required for normal mitosis and risk of breast cancer
J. E. Olson, X. Wang, E. L. Goode, V. S. Pankratz, Z. S. Fredericksen, R. A. Vierkant, P. D. P. Pharoah, J. R. Cerhan, F. J. Couch
Mutations in the mitochondrial DNA D-loop region and breast cancer risk
Chuanzhong Ye, Xiao Ou Shu, Larry Pierce, Wanqing Wen, Regina Courtney, Yu-Tang Gao, Wei Zheng, Qiuyin Cai
The TGFBR1*6A/9A polymorphism is not associated with differential risk of breast cancer
Gabrielle Colleran, Niall McInerney, Andrew Rowan, Ella Barclay, Angela M. Jones, Catherine Curran, Nicola Miller, Michael Kerin, Ian Tomlinson, Elinor Sawyer
ATM germline mutations in women with familial breast cancer and a relative with haematological malignancy
Laura La Paglia, Anthony Laugé, Jérémie Weber, Jérôme Champ, Eve Cavaciuti, Antonio Russo, Jean-Louis Viovy, Dominique Stoppa-Lyonnet
Association of genetic variation in mitotic kinases with breast cancer risk
Xianshu Wang, Zachary S. Fredericksen, Robert A. Vierkant, Matthew L. Kosel, V. Shane Pankratz, James R. Cerhan, Christina Justenhoven, Hiltrud Brauch, Janet E. Olson, Fergus J. Couch
Green tea consumption and breast cancer risk or recurrence: a meta-analysis
Adeyemi A. Ogunleye, Fei Xue, Karin B. Michels
Are mammography recommendations in women younger than 40 related to increased risk?
Julie M. Kapp, Bonnie C. Yankaskas, Michael L. LeFevre
Frequent somatic mutations of GATA3 in non-BRCA1/BRCA2 familial breast tumors, but not in BRCA1-, BRCA2- or sporadic breast tumors
Jeremy M. Arnold, David Y. H. Choong, Ella R. Thompson, Nic Waddell, Geoffrey J. Lindeman, Jane E. Visvader, Ian G. Campbell, Georgia Chenevix-Trench
Soluble factors derived from tumor mammary cell lines induce a stromal mammary adipose reversion in human and mice adipose cells. Possible role of TGF-β1 and TNF-α
Javier Guerrero, Nicolás Tobar, Mónica Cáceres, Lorena Espinoza, Paula Escobar, Javier Dotor, Patricio C. Smith, Jorge Martínez
Association between polymorphisms of XRCC1 and offspring sex ratio at births in families of female breast cancer patients
Mostafa Saadat, Iraj Saadat